arrow
Back
P

Peter E. Zage

University of California San Diego

30H-index
129Paper Count
2.4KCitation Count
Published Papers 40
Publication Date
Publisher Correction: Multimodal cell maps as a foundation for structural and functional genomics
errNature
IF48.5
err2025-10-02
err0
errOAAI
errLeah V. Schaffer; Mengzhou Hu; Gege Qian; Kyung-Mee Moon; Abantika Pal; Neelesh Soni; Andrew P. Latham; Laura Pontano Vaites; Dorothy Tsai; Nicole M. Mattson; Katherine Licon; Robin Bachelder; Anthony Cesnik; Ishan Gaur; Trang Le; William Leineweber; Aji Palar; Ernst Pulido; Yue Qin; Xiaoyu Zhao; Christopher Churas; Joanna Lenkiewicz; Jing Chen; Keiichiro Ono; Dexter Pratt; Peter Zage; Ignacia Echeverria; Andrej Sali; J. Wade Harper; Steven P. Gygi; Leonard J. Foster; Edward L. Huttlin; Emma Lundberg; Trey Ideker
errShare
errSave
A map of osteosarcoma cell architecture reveals convergence of pediatric cancer mutations on protein assemblies
err2024-03-22
err0
PREAI
errHu, Mengzhou; Schaffer, Leah V.; Huttlin, Edward L.; Qian, Gege; Latham, Andrew; Pal, Abantika; Vaites, Laura Pontano; Le, Trang; Qin, Yue; Churas, Christopher; Pratt, Dexter; Bachelder, Robin; Zage, Peter; Echeverria, Ignacia; Sali, Andrej; Harper, J. Wade; Gygi, Steven P.; Lundberg, Emma; Ideker, Trey
errShare
errSave
errShare
errSave
errShare
errSave
Targeting the RET tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy
err2023-10-01
err7
errOAAI
errSteen, Erica A.; Basilaia, Mariam; Kim, William; Getz, Taelor; Gustafson, Jeffrey L.; Zage, Peter E.
errShare
errSave
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma
err2023-05-29
err3
errOAAI
errEslin, Don; Zage, Peter E.; Bergendahl, Genevieve; Lewis, Elizabeth; Roberts, William; Kraveka, Jacqueline; Mitchell, Deanna; Isakoff, Michael S.; Rawwas, Jawhar; Wada, Randal K.; Fluchel, Mark; Brown, Valerie I.; Ginn, Kevin; Higgins, Timothy; BeeravallyNagulapally, Abhinav; Dykema, Karl; Hanna, Gina; Ferguson, William; Saulnier Sholler, Giselle L.
errShare
errSave
USP7 is a promising thersapeutic target for neuroblastoma
err2023-04-04
err0
PREAI
errLe Clorennec, Christophe; Lee, Karen; Zage, Peter
errShare
errSave
Identification of a novel gene signature for neuroblastoma differentiation using a Boolean implication network
err2023-02-13
err1
errOAAI
errZage, Peter E.; Huo, Yuchen; Subramonian, Divya; Le Clorennec, Christophe; Ghosh, Pradipta; Sahoo, Debashis
errShare
errSave
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
err2022-03-04
err2
errOAAI
errSen, Arko; Huo, Yuchen; Elster, Jennifer; Zage, Peter E.; McVicker, Graham
errShare
errSave
The roles of E3/E4 ubiquitin ligase UBE4B and its targets p53 and Ku70 in neuroblastoma cell death and differentiation
err2020-08-15
err0
PREAI
errLe Clorennec, Christophe; Lesperance, Jacqueline; Huo, Yuchen; Zage, Peter E.
errShare
errSave
Inhibition of RET via BLU-667 in an in vitro model of neuroblastoma
err2020-08-15
err1
PREAI
errGutierrez, Jessica; Flynn, Sean; Huo, Yuchen; Lesperance, Jacqueline; Zage, Peter
errShare
errSave
Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways
err2020-05-27
err37
errOAAI
errSubramonian, Divya; Phanhthilath, Nikki; Rinehardt, Hannah; Flynn, Sean; Huo, Yuchen; Zhang, Jing; Messer, Karen; Mo, Qianxing; Huang, Shixia; Lesperance, Jacqueline; Zage, Peter E.
errShare
errSave
Characterization of G-CSF receptor expression in medulloblastoma
err2020-05-27
err6
errOAAI
errPaul, Megan Rose; Huo, Yuchen; Liu, Andrea; Lesperance, Jacqueline; Garancher, Alexandra; Wechsler-Reya, Robert J.; Zage, Peter E.
errShare
errSave
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
err2020-05-24
err41
errOAAI
errLewis, Elizabeth C.; Kraveka, Jacqueline M.; Ferguson, William; Eslin, Don; Brown, Valerie, I; Bergendahl, Genevieve; Roberts, William; Wada, Randal K.; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Zage, Peter; Rawwas, Jawhar; Rich, Maria; Lorenzi, Elizabeth; Broglio, Kristine; Berry, Donald; Sholler, Giselle L. Saulnier
errShare
errSave
Mechanisms of Efficacy of the FGFR1-3 Inhibitor AZD4547 in Pediatric Solid Tumor Models
err2020-05-20
err8
PREAI
errPhanhthilath, Nikki; Hakim, Sara; Su, Catherine; Liu, Andrea; Subramonian, Divya; Lesperance, Jacqueline; Zage, Peter E.
errShare
errSave
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
err2018-09-27
err82
errOAAI
errSholler, Giselle L. Saulnier; Ferguson, William; Bergendahl, Genevieve; Bond, Jeffrey P.; Neville, Kathleen; Eslin, Don; Brown, Valerie; Roberts, William; Wada, Randal K.; Oesterheld, Javier; Mitchell, Deanna; Foley, Jessica; Parikh, Nehal S.; Eshun, Francis; Zage, Peter; Rawwas, Jawhar; Sencer, Susan; Pankiewicz, Debra; Quinn, Monique; Rich, Maria; Junewick, Joseph; Kraveka, Jacqueline M.
errShare
errSave
Growth factor receptor trafficking in neuroblastoma differentiation
err2018-07-01
err0
PREAI
errLesperance, Jacqueline; Subramonian, Divya; Woodfield, Sarah; Guo, Rongjun; Bean, Andrew; Lopez-Terrada, Dolores; Ittmann, Michael; Hakim, Sara; Zage, Peter E.
errShare
errSave
The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma
err2016-09-01
err20
PREAI
errWhittle, Sarah B.; Patel, Kalyani; Zhang, Linna; Woodfield, Sarah E.; Du, Michael; Smith, Valeria; Zage, Peter E.
errShare
errSave
errShare
errSave